APDEYA
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Sept 2024)
What this means for you
This application is over — abandoned 09 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97515693
- Mark type
- Stylized text
- Filed
- 22 Jul 2022
- Published for opposition
- 13 Jun 2023
- Abandoned
- 09 Sept 2024
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, nephrological, autoimmune, immunological, ocular, neurological and inflammatory related diseases and disorders
Owner
- Alexion Pharmaceuticals, Inc., Boston, MA, US
- Alexion Pharmaceuticals, Inc., Boston, MA, US
Prosecution history
- 09 Sept 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Sept 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 24 May 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 May 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 May 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 11 Apr 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 11 Apr 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2024 — SOU EXTENSION 1 GRANTED
- 09 Jan 2024 — SOU EXTENSION 1 FILED
- 09 Jan 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Aug 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jun 2023 — PUBLISHED FOR OPPOSITION